Cambridge Investment Research Advisors »

Silverback Therapeutics shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Silverback Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 290.9M1M1.1M1.2M87.157k87.1575k87.158k87.1585k87.159k
Value ($)Share countHistorical SPRY position of Cambridge Investment Research … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $920k 87k 10.56
2024-09-30 $1.3M 87k 14.50

More positions owned by Cambridge Investment Research Advisors

Apple Inc Com (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Microsoft Corp Com (MSFT)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Tesla Inc Com (TSLA)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Cambridge Investment Research Advisors

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics